- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 20.89M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 21.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 20.66M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $7.96M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $7.95M |
| Capex | Q1 2026 · Mar 31, 2026 | $604K |
| Capex | Q1 2026 · Mar 31, 2025 | $745K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.44M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $2.25M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $17.08M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $25.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $140.96M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $146.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $151.74M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $154.75M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $43.45M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $49.11M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $52.93M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $59.73M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $47.22M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $57.88M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $193.89M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $206.11M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.09 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.25 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.63M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $7.87M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.46M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $3.09M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.99M |
| Net Income | Q1 2026 · Mar 31, 2025 | $5.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.44M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $6.02M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $7.73M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $7.28M |
| Revenue | Q1 2026 · Mar 31, 2026 | $33.23M |
| Revenue | Q1 2026 · Mar 31, 2025 | $36.29M |